Yatharth Hospital & Trauma Care Services

YATHARTH · NSE

— · —

₹1,108

Closing price — 29 Sept 2026

Market cap ₹10,675 Cr · EPS ₹10.01

Valuation

Blended fair value using DCF and peer comparison methods.

See if Yatharth Hospital & Trauma Care Services is undervalued

Unlock intrinsic value for 4,800+ Indian stocks — free.

The intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.

Peer comparison

How this company stacks up against sector peers on valuation and quality metrics.

Hospitals & healthcare services · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
Yatharth Hospital & Trauma Care Services YATHARTH · you	₹10,675 Cr	110.7×	12.2×	—	11.0%	0.2%	—
Sector median	—	53.6×	8.8×	28.2×	15.9%	9.0%	17.9%
Aster DM Healthcare ASTERDM	₹40,777 Cr	105.1×	8.9×	47.6×	8.5%	8.4%	15.7%
Narayana Hrudayalaya NH	₹39,489 Cr	47.9×	8.6×	28.2×	17.8%	10.2%	20.4%
Krishna Institute of Medical Sciences KIMS	₹33,983 Cr	126.6×	17.0×	—	13.4%	0.1%	—
Global Health MEDANTA	₹33,396 Cr	60.1×	8.4×	37.0×	14.0%	12.6%	17.9%
Rainbow Childrens Medicare RAINBOW	₹14,871 Cr	59.3×	10.9×	—	18.4%	0.1%	—
Indraprastha Medical Corporation Limited INDRAMEDCO	₹3,375 Cr	18.6×	4.6×	11.6×	24.8%	12.4%	10.5%
Dr Agarwals Eye Hospital Limited DRAGARWQ	₹2,612 Cr	34.3×	14.2×	—	41.4%	0.2%	—
Medi Assist Healthcare Services Limited MEDIASSIST	₹2,300 Cr	30.4×	3.3×	12.7×	10.5%	9.7%	21.5%

Peer comparison verdict

Yatharth trades at a premium to sector peers on P/E (110.7× vs median 53.6×). The market is pricing in higher growth — worth verifying whether recent revenue trends support that expectation.

Business quality

Valuation

P/E ratio

110.7×

P/B ratio

—

EV/EBITDA

—

Price/Sales

—

Returns

ROE

11.0%

ROCE

—

ROA

—

Growth

Revenue CAGR (3yr)

—

EPS CAGR (3yr)

—

Efficiency

Asset turnover

—

FCF yield

—

Dividend yield

—

Liquidity & Solvency

Debt / Equity

—

Debt / EBITDA

—

Interest coverage

—

Current ratio

—

Quick ratio

—

Financial health

Piotroski F-Score, Altman Z-Score, and key solvency ratios.

Financial health data is not yet available for this company.

Full financial data

Charts and annual statements for income, balance sheet and cash flow.

Income trend

Revenue, profit and margin trends over time.

Income statement data is unavailable for this company.

Cash flow

Where cash comes from and where it goes.

Cash flow data is not yet available for this company.

Balance sheet

Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.

Balance sheet data is not yet available for this company.

Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.

Shareholding pattern

Who owns this company and how that has changed.

Shareholding data is not yet available for this company.